18 / 19
Cost constraints in oncology: Europe
•
Global spend on oncology drugs is increasing year on year
•
E.g. cancer drug budgets doubled in France in 4 years
1
•
How can we respond to cost constraints?
•
Better use of existing techniques,
avoidance of futile treatments
•
Restrict access of new drugs to patients?
•
Co-payment?
•
Reduce costs through adoption of biosimilars?:
YES
0
200
400
600
800
1000
1200
2004
2008
Millions of Euros